Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 3Meningeal Carcinomatosis 1Glioma 1

Interventions

Pemetrexed 4Spinal Puncture 3Radiotherapy 3aflutinib 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Bevacizumab 2toripalimab 1sintilimab 1pertuzumab 1lorlatinib 1azeliragon 1adavosertib 1Trastuzumab 1Referral and Consultation 1Radiation 1Physical Examination 1Immunotherapy, Adoptive 1Immune Checkpoint Inhibitors 1GDC-0084 1Drug Therapy 1Deferoxamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Carcinomatosis × azeliragon × 90 days × Clear all
NCT06724926 2026-05-18

Concurrent Azeliragon With Craniospinal Irradiation

NYU Langone Health

Phase 1 Active not recruiting
21 enrolled
CNS

Glioma, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡